Imagin Medical Receives Approval for 1st In-human Research Study
27. September 2017 17:22 ET
|
Imagin Medical Inc.
VANCOUVER, BC and BOSTON, MA--(Marketwired - September 27, 2017) - Imagin Medical, Inc. (CSE: IME) (CSE: IME.CN) (CNSX: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (the "Company") announced today that...
Functional Prototype Complete -- Imagin Medical Chooses Optel to Design i/Blue Prototype for Commercialization
08. Dezember 2016 08:00 ET
|
Imagin Medical Inc.
VANCOUVER, BC and BOSTON, MA--(Marketwired - December 08, 2016) - Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (the "Company") announced today that it is partnering with Optel,...
Imagin Medical Completes Development of i/Blue Alpha B Prototype
01. Dezember 2016 08:00 ET
|
Imagin Medical Inc.
VANCOUVER, BC and BOSTON, MA--(Marketwired - December 01, 2016) - Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (the "Company") announced today that it has completed development of...
Liam J. Hurley, M.D. FACS Joins Imagin Medical's Scientific Board of Advisors
27. Oktober 2016 08:00 ET
|
Imagin Medical Inc.
VANCOUVER, BC and BOSTON, MA--(Marketwired - October 27, 2016) - Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (the "Company") announced today that Dr. Liam J. Hurley, a member of...
Imagin Medical Closes Tranche I of Private Placement for $385,800
20. Oktober 2016 08:30 ET
|
Imagin Medical Inc.
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in the early detection of bladder cancer through...
Imagin's Quality Management System Initial Phase Complete
06. Oktober 2016 08:00 ET
|
Imagin Medical Inc.
VANCOUVER, BC and BOSTON, MA--(Marketwired - October 06, 2016) - Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (the "Company") announced today that the Company's Quality Plan for...
Ken Daignault Joins Imagin Medical's Board of Directors
29. September 2016 08:00 ET
|
Imagin Medical Inc.
VANCOUVER, BC and BOSTON, MA --(Marketwired - September 29, 2016) - Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (the "Company") announced today that Ken Daignault has joined Imagin's...
Dr. Edward Messing, Chief of Urology, U Rochester Medical Center Joins Imagin Medical's Scientific Board of Advisors
22. September 2016 08:30 ET
|
Imagin Medical Inc.
VANCOUVER, BC and BOSTON, MA--(Marketwired - September 22, 2016) - Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (the "Company") announced today that Dr. Edward Messing, Chair of...
Disruptive Cancer Detection Technology Update
15. September 2016 08:30 ET
|
Imagin Medical Inc.
VANCOUVER, BC and BOSTON, MA--(Marketwired - September 15, 2016) - Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (the "Company") As a follow up to Imagin's announcement of an $800,000...
American Urological Association New Bladder Cancer Guidelines Support Imagin Medical's Objective
02. August 2016 09:00 ET
|
Imagin Medical Inc.
VANCOUVER, BC and BOSTON, MA--(Marketwired - August 02, 2016) - Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (the "Company") is announcing that the recent publication of the new...